ZA200903898B - Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors - Google Patents

Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors

Info

Publication number
ZA200903898B
ZA200903898B ZA200903898A ZA200903898A ZA200903898B ZA 200903898 B ZA200903898 B ZA 200903898B ZA 200903898 A ZA200903898 A ZA 200903898A ZA 200903898 A ZA200903898 A ZA 200903898A ZA 200903898 B ZA200903898 B ZA 200903898B
Authority
ZA
South Africa
Prior art keywords
parp
adp
ribose
polymerase
inhibitors
Prior art date
Application number
ZA200903898A
Other languages
English (en)
Inventor
Philip Jones
Ontoria Jesus Maria Ontoria
Rita Scarpelli
Carsten Schultz-Fademrecht
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200903898(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Publication of ZA200903898B publication Critical patent/ZA200903898B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200903898A 2007-01-10 2009-06-04 Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors ZA200903898B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0700432.8A GB0700432D0 (en) 2007-01-10 2007-01-10 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ZA200903898B true ZA200903898B (en) 2010-04-28

Family

ID=37809722

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903898A ZA200903898B (en) 2007-01-10 2009-06-04 Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors

Country Status (21)

Country Link
CN (1) CN101578279B (da)
AT (1) ATE502933T1 (da)
CR (1) CR10910A (da)
DE (1) DE602008005711D1 (da)
DK (2) DK2109608T3 (da)
ES (3) ES2509115T3 (da)
GB (1) GB0700432D0 (da)
HN (1) HN2009001260A (da)
HU (1) HUE044513T2 (da)
LT (1) LT2805945T (da)
LU (1) LUC00072I2 (da)
ME (1) ME03481B (da)
MY (1) MY147789A (da)
NI (1) NI200900135A (da)
NZ (1) NZ578256A (da)
PE (1) PE20081558A1 (da)
PT (3) PT2805945T (da)
SI (2) SI2336120T1 (da)
TW (1) TWI528961B (da)
UA (1) UA97658C2 (da)
ZA (1) ZA200903898B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106496187A (zh) * 2016-09-14 2017-03-15 陕西科技大学 一种制备PARP抑制剂Niraparib的合成方法
CN106432188A (zh) * 2016-09-17 2017-02-22 青岛辰达生物科技有限公司 一种抗癌药2‑[4‑((3s)‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的制备方法
CN106432187A (zh) * 2016-09-17 2017-02-22 青岛云天生物技术有限公司 2‑[4‑(‑3‑哌啶基)苯基]‑2h‑吲唑‑7‑甲酰胺的手性拆分方法
CN106632244A (zh) * 2016-09-30 2017-05-10 陕西科技大学 一种制备抗癌药物Niraparib的新型合成方法
CN106467513A (zh) * 2016-09-30 2017-03-01 陕西科技大学 一种制备Niraparib的合成方法
CN108201537A (zh) * 2016-12-16 2018-06-26 苏州苏融生物医药有限公司 一种尼拉帕尼缓控释药物组合物及其用途
CA3058372A1 (en) * 2017-03-27 2018-10-04 Tesaro, Inc. Niraparib formulations
CN109081828B (zh) * 2017-06-14 2021-03-26 上海时莱生物技术有限公司 聚(adp-核糖)聚合酶抑制剂、制备方法及用途
CA3076907A1 (en) 2017-09-26 2019-04-04 Tesaro, Inc. Niraparib formulations
CN108084157A (zh) * 2018-02-12 2018-05-29 安庆奇创药业有限公司 一种尼拉帕尼的合成方法
CN108203404A (zh) * 2018-03-02 2018-06-26 上海博邦医药科技有限公司 (r)-3-苯基哌啶或/和(s)-3-苯基哌啶以及尼拉帕尼的手性中间体的合成方法
JP2023514794A (ja) 2020-02-24 2023-04-10 フーカン(シャンハイ) ヘルス テクノロジー カンパニー、 リミテッド ポリadpリボースポリメラーゼ阻害剤の抗コロナウイルス応用

Also Published As

Publication number Publication date
ATE502933T1 (de) 2011-04-15
ES2728199T3 (es) 2019-10-22
GB0700432D0 (en) 2007-02-21
CN101578279B (zh) 2013-07-17
PT2336120E (pt) 2014-10-01
ME03481B (me) 2020-01-20
UA97658C2 (ru) 2012-03-12
NZ578256A (en) 2011-12-22
PT2805945T (pt) 2019-06-06
SI2336120T1 (sl) 2014-10-30
DK2109608T3 (da) 2011-07-11
CR10910A (es) 2010-01-19
LT2805945T (lt) 2019-06-25
NI200900135A (es) 2010-08-30
HN2009001260A (es) 2012-03-26
PE20081558A1 (es) 2008-10-30
MY147789A (en) 2013-01-31
DK2336120T3 (da) 2014-10-06
LUC00072I2 (fr) 2018-07-04
SI2109608T1 (sl) 2011-07-29
TW200836731A (en) 2008-09-16
HUE044513T2 (hu) 2019-10-28
PT2109608E (pt) 2011-05-30
CN101578279A (zh) 2009-11-11
ES2509115T3 (es) 2014-10-17
TWI528961B (zh) 2016-04-11
ES2362214T3 (es) 2011-06-29
DE602008005711D1 (de) 2011-05-05

Similar Documents

Publication Publication Date Title
MX2009007200A (es) Indazoles sustituidos con amida como inhibidores de poli(adp-ribosa)polimerasa (parp).
ZA200903898B (en) Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors
MX2010005070A (es) Derivados de piridazinona como inhibidores de parp.
WO2007138351A3 (en) Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
MX2012002179A (es) Compuestos heterociclicos de oxima.
WO2008103277A3 (en) Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
MX339759B (es) Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
ATE543811T1 (de) Pyridazinderivate als faktor-xia-inhibitoren
EA201190158A1 (ru) Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
WO2010045251A3 (en) Spiro-oxindole compounds and their use as therapeutic agents
MX2012001838A (es) Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion.
WO2008017883A3 (en) 4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
EA201070864A1 (ru) Новые гетероциклические соединения
MX2012007582A (es) Compuestos de 4-fenoxi-nicotinamida o 4-fenoxi-pirimidina-5-carbox amida.
WO2011147951A8 (en) Cycloamino derivatives as gpr119 agonists
PH12015500418A1 (en) Pyridine derivative and medicine
GB201114389D0 (en) Novel compounds
TR201901937T4 (tr) 8-metil-1-fenil-imidazol[1,5-a]pirazin bileşikleri.